Dextromethorphan for Treatment of Postoperative Pain
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Nathanael Heckmann
- Study ID
- NCT05278494
- Status
- Recruiting
Conditions
- Post-operative Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dextromethorphan Hydrobromide — DRUGPO
- Placebo — DRUGPO
Study Details
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan compared to Placebo for the Treatment of Postoperative Pain
Key Dates
- Start date
- Sep 15, 2022
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dextromethorphan
- Placebo Comparator: Placebo
Primary Outcome Measure
Post-op opioid use [ Time Frame: 24 hours ]
Central Contacts
- Pui Yan, MS323-442-6984
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Keck School of Medicine of USC | Los Angeles | California | 90033 | Pui Yan, MS |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Force Sensor StudyRecruiting · University of California, San Francisco · San Francisco, California
- Dextenza in the Post-op Management of Vitreoretinal SurgeriesPHASE4 · Recruiting · The Cleveland Clinic · Cleveland, Ohio
- Post-operative Cesarean Trial of Pain ControlRecruiting · University of Colorado, Denver · Aurora, Colorado
- Subpectoral Bupivacaine for Pain Management in Adolescent Reduction MammaplastyPHASE4 · Recruiting · Connecticut Children's Medical Center · Farmington, Connecticut